Medical Footwear Market

Market Overview:

The global medical footwear market size reached US$ 10.6 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 16.9 Billion by 2032, exhibiting a growth rate (CAGR) of 5% during 2024-2032.

Medical footwear refers to specially designed footwear that assists in the treatment of various foot-related medical ailments. Some of these health conditions include arthritis, plantar fasciitis, bunions and hallux valgus, and Achilles tendonitis. It is also being utilized by individuals with flat feet and diabetes. Wearing it on a regular basis ensures proper blood circulation in the users’ body while offering enhanced support to their feet. These shoes can be customized as well to meet the specific requirements of the customer.

The market is primarily driven by the rising incidences of foot-related conditions. Medical issues, including foot and ankle injuries, corns, flat feet and arthritis, have impelled the masses to invest in good-quality medical footwear that provides a cushion to the entire foot while promoting mobility, support and healthy blood circulation. Along with this, increasing foot care awareness among individuals is expected to facilitate the uptake of these shoes. The market is further driven by the increasing prevalence of diabetes across the globe. Poorly controlled blood sugar levels among patients can often damage the nerves and vessels present in the legs and feet, resulting in the development of peripheral neuropathy. This condition is characterized by tingling sensation, numbness, muscle weakness and pain in the affected area. As a result, diabetic patients increasingly prefer the use of medical footwear to prevent the development of neuropathy or provide support to their ankle and foot in case of its onset. Some of the other factors contributing to the market growth include the increased consumer spending and the easy product availability through various pharmacies and online retail channels.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global medical footwear market report, along with forecasts at the global, regional and country levels from 2024-2032. Our report has categorized the market based on end user and distribution channel.

Breakup by End User:

• Men
• Women
   

Breakup by Distribution Channel:

• Offline
• Online
   

Breakup by Region:

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa
   

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Aetrex Worldwide Inc., Darco International Inc. (Wright Medical Group N.V.), Djo LLC (Colfax Corporation), Dr. Foot Inc., Dr. Zen Inc., Drewshoe Incorporated, Duna Srl, Gravity Defyer Corp., Horng Shin Footwear Co., Mephisto S.A.S, New Balance Inc., Orthofeet Inc. and Podartis srl.

Report Coverage:

Key Questions Answered in This Report:

• How has the global medical footwear market performed so far and how will it perform in the coming years?
• What has been the impact of COVID-19 on the global medical footwear market?
• What are the key regional markets?
• What is the breakup of the market based on the end user?
• What is the breakup of the market based on the distribution channel?
• What are the various stages in the value chain of the industry?
• What are the key driving factors and challenges in the industry?
• What is the structure of the global medical footwear market and who are the key players?
• What is the degree of competition in the industry?